Last updated on August 2018

Setmelanotide for the Treatment of Early-Onset POMC Deficiency Obesity


Brief description of study

The purpose of the study is to determine the effect of setmelanotide (RM-493) on weight and other factors in patients with pro-opiomelanocortin (POMC) deficiency obesity due to rare bi-allelic loss-of function POMC or PCSK1 genetic mutations.

Clinical Study Identifier: NCT02896192

Contact Investigators or Research Sites near you

Start Over

Sadaf Farooqi, PhD FRCP FMedSci

University of Cambridge Metabolic Research Laboratories
Cambridge, United Kingdom
0.03miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.